Multiple ureteral stent shapes, sizes, compositions, and designs have been studied to decrease patient discomfort during ureteral stent placement and indwelling time. However, the precise etiology of pain during ureteral stent indwelling remains elusive (
1). Encrustation is a well-established complication of retained biomaterials in the urinary tract. Severe stent encrustation is a potentially serious complication of prolonged indwelling ureteral stenting often managed by open surgery when endoscopic techniques are unsuccessful (
2). Ureteral stents are widely used in urologic daily practices and they have proved to be an invaluable tool in the armamentarium of the urological surgeon, indicated in selected cases of transureteral lithotripsy (TUL), after surgical ureteral repairs (like pyeloplasty and uretero-ureterostomy), and also as an adjunct to ureteral reconstruction in renal transplantation that may help to reduce early postoperative complications such as leakage and stricture (
3). Extrinsic ureteral obstruction can be managed successfully by ureteral stent placement. In many gynecological operations, ureteral stents may be used, too (
4,
5). However, stents can cause significant complications including migration, fragmentation, and encrustation, and it may possibly be forgotten. Successful management of a retained, encrusted stent requires combined endourological approaches. Percutaneous nephrostolithotomy (PCNL), ureteroscopy (URS), and transurethral lithotripsy or percutaneous cystolithotripsy (PCCL), are often necessary for treating a severely encrusted stent and associated stone burden (
6).